Trials that use: MMRM (mixed model for repeated measures)
New to this method? Read the tutorial →
3,925 results
- High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders: Complete Statistical AnalysisIndependent statistical analysis of High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: Complete Statistical AnalysisIndependent statistical analysis of High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB): Complete Statistical AnalysisIndependent statistical analysis of High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HIIT-SCIIndependent statistical analysis of Feasibility of HIIT in Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03152110).
- HIP: Hip Imaging Protocol: Complete Statistical AnalysisIndependent statistical analysis of HIP: Hip Imaging Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04126161).
- HIPPERIndependent statistical analysis of Feasibility of the Hip Instructional Prehabilitation Program for Enhanced Recovery (HIPPER): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HIPPOIndependent statistical analysis of Helping Improve Pediatric Patient Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03471221).
- Histological Comparison of Ridge Preservation Using Mineralized FDBA Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft: Complete Statistical AnalysisIndependent statistical analysis of Histological Comparison of Ridge Preservation Using Mineralized FDBA Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Histopathological Evaluation of the Periodontal Ligament Subjected to Laser Ablation.: Complete Statistical AnalysisIndependent statistical analysis of Histopathological Evaluation of the Periodontal Ligament Subjected to Laser Ablation.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06173648).
- HMO Research Network CERT: Acute Myocardial Infarction: Complete Statistical AnalysisIndependent statistical analysis of HMO Research Network CERT: Acute Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00211172).
- HNC-RCIndependent statistical analysis of Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Home Based Daratumumab Administration for Patients With Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Home Based Daratumumab Administration for Patients With Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05511428).
- Home Pulmonary Rehabilitation for COPD: Complete Statistical AnalysisIndependent statistical analysis of Home Pulmonary Rehabilitation for COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03480386).
- Home-based tDCS and Mindfulness-based Meditation for Self-management of Clinical Pain and Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Home-based tDCS and Mindfulness-based Meditation for Self-management of Clinical Pain and Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Home-based Telehealth Stroke Care: A Randomized Trial for Veterans: Complete Statistical AnalysisIndependent statistical analysis of Home-based Telehealth Stroke Care: A Randomized Trial for Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00384748).
- Homeopathic Cold Medicine for Children: Complete Statistical AnalysisIndependent statistical analysis of Homeopathic Cold Medicine for Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00858494).
- HOPE Kids 2Independent statistical analysis of Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HORIZON-HCMIndependent statistical analysis of A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05414175).
- HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005: Complete Statistical AnalysisIndependent statistical analysis of HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HSDDIndependent statistical analysis of 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease: Complete Statistical AnalysisIndependent statistical analysis of Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Human Lung Responses to Respiratory Pathogens: Complete Statistical AnalysisIndependent statistical analysis of Human Lung Responses to Respiratory Pathogens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01967628).
- Human Perception of Odors and Odor Blockers: Complete Statistical AnalysisIndependent statistical analysis of Human Perception of Odors and Odor Blockers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06191419).
- HUPKIndependent statistical analysis of Pharmacokinetics of Oral Hydroxyurea Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03763656).
- Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02463097).
- Hydration Factor Study for the Stayhealthy BC3: Complete Statistical AnalysisIndependent statistical analysis of Hydration Factor Study for the Stayhealthy BC3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01209936).
- Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00902538).
- Hydroxychloroquine and Cognitive Function After Surgery: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine and Cognitive Function After Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03025087).
- Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HYPEROXIA Responses and ROS: Complete Statistical AnalysisIndependent statistical analysis of HYPEROXIA Responses and ROS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05958303).
- Hypnotherapy With Audiofiles for Children and Adolescents With Disorders of Gut-brain Interactions in Sweden -a Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Hypnotherapy With Audiofiles for Children and Adolescents With Disorders of Gut-brain Interactions in Sweden -a Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- HypoANSIndependent statistical analysis of Hypoglycemia and Autonomic Nervous System Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01816893).
- Hypothyroidism Treated With Calcitonin: Complete Statistical AnalysisIndependent statistical analysis of Hypothyroidism Treated With Calcitonin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03342001).
- I2PETHVIndependent statistical analysis of I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02323217).
- IASISIndependent statistical analysis of Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- iATTENDIndependent statistical analysis of The Improving ATTENDance to Cardiac Rehabilitation Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03646760).
- Ibuprofen Extended-Release Dental Pain Study: Complete Statistical AnalysisIndependent statistical analysis of Ibuprofen Extended-Release Dental Pain Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00707057).
- Ibuprofen With or Without Acetaminophen for Low Back Pain: Complete Statistical AnalysisIndependent statistical analysis of Ibuprofen With or Without Acetaminophen for Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03554018).
- iCareIndependent statistical analysis of iCare Stress Management e-Training for Dementia Family Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01378195).
- Ictal and Interictal Inflammatory Markers in Migraine: Complete Statistical AnalysisIndependent statistical analysis of Ictal and Interictal Inflammatory Markers in Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01138150).
- ID11-56Independent statistical analysis of An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- iDCLIndependent statistical analysis of The International Diabetes Closed Loop (iDCL) Trial: Protocol 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02985866).
- IDEALEIndependent statistical analysis of Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study):…
- Identifying and Treating Depression in Hemodialysis Patients: Complete Statistical AnalysisIndependent statistical analysis of Identifying and Treating Depression in Hemodialysis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03390933).
- IDENTITY-2Independent statistical analysis of Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- iDIETIndependent statistical analysis of The Immune Directed Individualized Elimination Therapy (iDIET) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05543512).
- IDMPCIndependent statistical analysis of Improving Depression Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05050227).
- IETPPEIndependent statistical analysis of Investigations of Ear Tip Performance, Perceptions, and Experiences: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05725824).
- IF-AMDIndependent statistical analysis of Improving Function in Age-Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00572039).